Skip to main content
. 2021 Feb 7;6(3):100665. doi: 10.1016/j.adro.2021.100665

Table 1.

Baseline clinical characteristics of patients with spinal metastases with radiologic imaging (n = 182)

Overall (N = 182)
Patients with local failure (n = 74)
Patients without local failure (n = 108)
Comparison of baseline characteristics (with vs without local failure)
No. % No. % No. % P value
Age at RT start (years)
 Median 60.5 - 59.5 - 61 - -
 Range 23-97 - 38-97 - 23-87 - -
Sex
 Female 100 54.9 35 47.3 65 60.2 .086
 Male 82 45.1 39 52.7 43 39.8
Time from metastatic diagnosis to RT start (years)
 Median 0.7 - 0.9 - 0.5 - -
 Range 0-12.4 - 0-9.1 - 0-12.4 - -
ECOG PS
 0 35 19.2 16 21.6 19 17.6 .835
 1 97 53.3 37 50 60 55.6
 2 34 18.7 15 20.3 19 17.6
 3 16 8.8 6 8.1 10 9.3
Histology
 Breast 40 22.0 9 12.2 31 28.7 .013
 Lung 43 23.6 17 23.0 26 24.1
 Prostate 32 17.6 17 23.0 15 13.9
 Kidney 10 5.5 8 10.8 2 1.8
 Melanoma 7 3.8 2 2.7 5 4.6
 Other 50 27.5 21 28.4 29 26.9
Metastatic burden
 1 41 22.5 18 24.3 23 21.3 .497
 2 58 31.9 24 32.4 34 31.5
 3 42 23.1 13 17.6 29 26.9
 ≥4 41 22.5 19 25.7 22 20.4
Spine level
 Cervical 8 4.4 4 5.4 4 3.7 .559
 Thoracic 84 46.2 30 40.5 54 50.0
 Lumbar 74 40.7 34 45.9 40 37.0
 Spine 16 8.8 6 8.1 10 9.3
SINS
 0-6 71 39.0 28 37.8 43 39.8 .786
 7-12 99 54.4 40 54.1 59 54.6
 ≥13 12 6.6 6 8.1 6 5.6
Ambulatory 172 94.5 69 93.2 103 95.4 .536
Cord compression 19 10.4 8 10.8 11 10.2 .892
Neuropathic pain 96 52.7 43 58.1 53 49.5 .230
Paraspinal disease 61 33.5 21 28.4 40 37.4 .224
Epidural involvement§ 99 54.4 43 68.3 56 59.6 .405
Total RT dose (Gy)
 Median 30 - 30 - 30 - -
 Range 8-40 - 8-40 - 8-37.5 - -
Dose regimens
 Single-fraction (8 Gy) 32 17.6 18 24.3 14 13.0 .048
 Multifraction 150 82.4 56 75.7 94 87.0
Cumulative BED
 40 Gy 32 17.6 18 24.3 14 13 .197
 41-60 Gy 29 15.9 11 14.9 18 16.7
 61-75 Gy 94 51.6 33 44.6 61 56.5
 ≥76 Gy 27 14.8 12 16.2 15 13.9
Number of vertebral bodies covered by RT
 1 2 1.1 0 0 2 1.9 .525
 2 1 0.5 0 0 1 0.9
 3 43 23.6 20 27 23 21.3
 4 50 27.5 20 27 30 27.8
 5 29 15.9 15 20.3 14 13
 6 19 10.4 5 6.8 14 13
 7 17 9.3 5 6.8 12 11.1
 8 10 5.5 5 6.8 5 4.6
 ≥9 11 6.0 4 5.4 7 6.5

Abbreviations: BED = biological equivalent dose; ECOG PS = Eastern Cooperative Oncology Group Performance Status; RT = radiation therapy; SINS = spinal instability neoplastic score.

Other histology includes: Adrenal (n = 1), carcinoid (n = 2), colon (n = 9), dermatofibroid (n = 1), endometrium/uterine (n = 4), esophagus (n = 14), head and neck (n = 9), leiomyosarcoma (n = 1), liposarcoma (n = 1), meningioma (n = 1), mesothelioma (n = 1), neuroendocrine (n = 2), nuclear protein in testis midline carcinoma (n = 1), pancreas (n = 4), sacromatoid (n = 1), salivary (n = 1), sarcoma (n = 9), skin (n = 3), stomach (n = 2), thyroid (n = 5), and urothelial (n = 9).

Metastatic burden refers to the number of systems with metastatic disease (eg, lung, liver, etc).

Presence of neuropathic pain and paraspinal disease was unknown for 1 patient, who did not experience local failure.

§

Presence of epidural involvement was unknown for 25 patients, 11 of whom experienced local failure.

Multifraction regimens included 20 Gy in 5 fractions (n = 20), 30 Gy in 10 fractions (n = 95), 35 to 37.5 Gy in 14 to 15 fractions (n = 23), and other radiation therapy regimens (n = 12).

BED refers to the biological equivalent dose of the cumulative dose of RT delivered to the spine